Skip to main content
. 2011 Feb 18;46(1):119–151. doi: 10.1080/00273171.2011.540480

TABLE 3.

Baseline Characteristics of Treated and Untreated Participants in the Final Propensity Score Matched Sample

Variable No Smoking Cessation Counseling (N = 646) Smoking Cessation Counseling (N = 646) Standardized Difference of the Mean Variance Ratio
Demographic Characteristics
Age 59.1 ± 12.4 58.7 ± 12.4 0.026 0.998
Female 178 (27.6%) 175 (27.1%) 0.010 0.989

Presenting Signs and Symptoms
Acute pulmonary edema 31 (4.8%) 25 (3.9%) 0.046 0.814

Vital Signs on Admission
Systolic blood pressure 147.7 ± 30.5 147.8 ± 31.3 0.002 1.055
Diastolic blood pressure 85.5 ± 17.7 85.7 ± 18.5 0.015 1.092
Heart rate 82.1 ± 22.4 82.4 ± 22.3 0.013 0.993
Respiratory rate 20.8 ± 5.5 20.9 ± 5.7 0.012 1.046

Classic Cardiac Risk Factors
Diabetes 130 (20.1%) 140 (21.7%) 0.038 1.056
Hyperlipidemia 216 (33.4%) 214 (33.1%) 0.007 0.995
Hypertension 247 (38.2%) 247 (38.2%) 0.000 1.000
Family history of coronary artery disease 218 (33.7%) 235 (36.4%) 0.055 1.035

Comorbid Conditions and Vascular History
Cerebrovascular accident/Transient ischemic attack 39 (6.0%) 46 (7.1%) 0.044 1.166
Angina 165 (25.5%) 166 (25.7%) 0.004 1.004
Cancer 15 (2.3%) 13 (2.0%) 0.021 0.869
Dementia 5 (0.8%) 8 (1.2%) 0.047 1.593
Previous myocardial infarction 131 (20.3%) 131 (20.3%) 0.000 1.000
Asthma 33 (5.1%) 35 (5.4%) 0.014 1.057
Depression 63 (9.8%) 63 (9.8%) 0.000 1.000
Peptic ulcer disease 30 (4.6%) 30 (4.6%) 0.000 1.000
Peripheral vascular disease 57 (8.8%) 57 (8.8%) 0.000 1.000
Previous coronary revascularization 44 (6.8%) 43 (6.7%) 0.006 0.979
Chronic congestive heart failure 13 (2.0%) 14 (2.2%) 0.011 1.075

Laboratory Tests
Glucose 9.0 ± 5.3 9.1 ± 5.5 0.011 1.075
White blood count 10.9 ±i 3.9 10.7 ± 3.6 0.038 0.863
Hemoglobin 143.2 ± 16.7 143.9 ± 17.6 0.041 1.117
Sodium 139.1 ± 3.5 139.0 ± 3.3 0.025 0.920
Potassium 4.0 ± 0.5 4.1 ± 0.5 0.004 1.151
Creatinine 93.8 ± 39.6 92.1 ± 40.2 0.045 1.033

Prescriptions for Cardiovascular Medications at Hospital Discharge
Statin 189 (29.3%) 185 (28.6%) 0.014 0.987
Beta-blocker 424 (65.6%) 427 (66.1%) 0.010 0.993
Angiotensin Converting Enzyme (ACE) inhibitor/Angiotensin receptor blockers 302 (46.7%) 309 (47.8%) 0.022 1.002
Plavix 24 (3.7%) 28 (4.3%) 0.031 1.159
Acetylsalicyclic Acid (ASA) 476 (73.7%) 488 (75.5%) 0.043 0.953

Note. Continuous variables are presented as means ± standard deviation; dichotomous variables are presented as N (%).